Therapeutics and COVID-19-A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Morten H Møller, Michelle S Chew, Klaus T Olkkola, Marius Rehn, Arvi Yli-Hankala, Martin Ingi Sigurðsson

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

Original languageEnglish
Pages (from-to)636-637
Number of pages2
JournalActa Anaesthesiologica Scandinavica
Volume66
Issue number5
DOIs
Publication statusPublished - 28 Feb 2022

Bibliographical note

Funding Information:
Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources.

Publisher Copyright:
© 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.

Other keywords

  • Anesthesiology
  • COVID-19
  • Critical Care
  • Humans
  • Societies, Medical
  • World Health Organization
  • therapeutics
  • AGREE II
  • clinical practice guideline
  • WHO

Fingerprint

Dive into the research topics of 'Therapeutics and COVID-19-A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine'. Together they form a unique fingerprint.

Cite this